Breaking Health

Alpha CEO Thor Ernstsson talks on the importance of making smarter product decisions through the right kind of user insight. Alpha builds a universal tool that tests the small incremental changes needed to improve engagement. With big name clients like Prudential, Pfizer, and Spotify, Alpha is proving the need for product versatility – within and outside of patient care.

Bob Sheehy, CEO and co-founder of Bright Health and veteran of the insurance game, shares his vision for a better healthcare system.

HealthPrize CEO Tom Kottler explains how we can save lives – and billions of dollars – by helping patients take their prescribed medications.

Curtis Duggan, Co-Founder and CEO of Blue Mesa, explains how the start-up is using mobile tech, wearables, and other tools to help people take control of their disease.

Yiding Yu, MD, founder and chief medical officer of Twiage, explains how her start-up is using mobile technologies to clear the line between the EMTs and ER personnel.

On this week’s installment of Breaking Health, Host Steve Krupa – CEO of the Psilos Group – dives into the intriguing story behind SolveBio, a company working to disrupt precision medicine.In this interview, Mark Kaganovich, PhD, CEO, and co-founder, discusses the benefits of SolveBio’s innovative data layer – called the “Genomic Intelligence Platform” – aimed at enabling pharma, biotech, and diagnostic organizations to effectively interact with genomic information.Founded in 2013 by graduate school classmates David Caplan, David Gross, and Kaganovich, SolveBio recognizes that isolated DNA sequencing technology has become increasingly essential in medicine and health care. But the process lacks accessible reference data that compares and cross references results from similar clinical trials, studies, and cases that may help decided company strategy or patient care. Kaganovich says the lack of context in genomics studies can sometimes be “mind boggling.”“This hasn’t really fully played out yet, but you’ll have people that make life-altering decisions based on a diagnostic report, and that report, where is the reference data for that? How do you know if you have a pathogenic variance or a benign variance?” Kaganovich asks. “It comes from some reference data set somewhere that probably some grad student contributed to some FTP site, and that kind of sat there. And then it was parsed out by a bioinformatician. It was normalized and some kind of quality control was done. But in the end, it comes from research often, or people don’t even know where it comes from. And to me, that’s kind of scary.”Where is SolveBio now? Dive with us into the episode here to learn in more detail about what the wider applications to SolveBio's mission could mean for health care tech and population care, and how its in-depth knowledge hub has already helped well-known customers.

Circulation co-founder and CEO Robin Heffernan explains how her start-up is working with the transportation giant to make it easier for patients to see a doctor.

Breaking Health Host Steve Krupa hears some exciting news from Optum’s Michael Weintraub and talks Analytics with Mudit Garg, founder and CEO of analyticsMD.

CEO Dan Burton, receiving the DHIS Innovator Award on behalf of the data warehouse company, speaks to strengths and values that have driven the company’s success.

Inspired by the sad tale of one patient, Kim founded One Caring Team to create a way to keep patients better connected through Virtual Reality.